AI assistant
SOLESENCE, INC. — Director's Dealing 2016
May 12, 2016
33563_dirs_2016-05-12_cfa41537-c423-4c4a-9ebe-939f7e323211.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: NANOPHASE TECHNOLOGIES Corp (NANX)
CIK: 0000883107
Period of Report: 2015-02-27
Reporting Person: HENDERSON JAMES A (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-02-27 | Common Stock | P | 27 | $0.51 | Acquired | 376620 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (right to buy) | $1.36 | 2021-01-31 | Common Stock (10000) | 10000 | Direct |
| Deferred Common Stock | $ | Common Stock (20030) | 20030 | Direct | |
| Stock Appreciation Right | $ | Common Stock (14000) | 14000 | Direct | |
| Stock Option (right to buy) | $0.30 | 2022-08-07 | Common Stock (15000) | 15000 | Direct |
| Stock Option (right to buy) | $0.415 | 2023-02-14 | Common Stock (15000) | 15000 | Direct |
| Stock Option (right to buy) | $0.52 | 2024-02-13 | Common Stock (15000) | 15000 | Direct |
| Common Stock (right to buy) | $0.44 | 2025-02-18 | Common Stock (13500) | 13500 | Direct |
| Common Stock | $0.42 | 2026-02-23 | Common Stock (12150) | 12150 | Direct |
Footnotes
F1: Subject to certain restrictions, beginning on this date, options vest in three equal annual installments.
F2: Each share of deferred common stock represents a right to receive one share of common stock.
F3: The deferred common stock becomes payable upon the reporting person's termination of service as a director of the Company.
F4: Pursuant to such plan, the reporting person elected to defer receipt of such shares and receive a cumulative total of 20,030 shares of deferred common stock which will all be accounted for under the Company's Non-Employee Director Deferred Compensation Plan.
F5: The stock appreciation right becomes payable upon the reporting person's termination of service as a director of the Company. 2,000 were issued 4/8/2009 at a conversion price of $0.90, 2,000 were issued 7/1/2009 at a conversion price of $1.05, 2,000 were issued 10/1/2009 at a conversion price of $1.18, 2,000 were issued 1/4/2010 at a conversion price of $0.84, 2,000 were issued 4/1/2010 at a conversion price of $1.85, 2,000 were issued 7/1/2010 at a conversion price of $1.10, and 2,000 were issued 10/1/2010 at a conversion price of $0.99.
F6: Subject to certain rights and restrictions, options vest in three equal annual installments.